Immunodeficiency Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Immunodeficiency stocks.

Immunodeficiency Stocks Recent News

Date Stock Title
Jul 3 GILD 5 FDA decisions to watch in the third quarter
Jul 2 INO INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer
Jul 2 GOVX (GOVX) - Analyzing Geovax Labs's Short Interest
Jul 2 CODX Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States
Jul 2 GILD Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE?
Jul 2 HOOK HOOKIPA Pharma doses first subject in Phase Ib HIV treatment trial
Jul 2 BMY Eisai and Bristol Myers Squibb terminate ADC development deal
Jul 2 GILD Insider Sale: Chief Medical Officer Merdad Parsey Sells Shares of Gilead Sciences Inc (GILD)
Jul 1 HOOK HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
Jul 1 BMY Eisai receives rights to antibody drug conjugate after Bristol ends collaboration
Jul 1 BMY What the Options Market Tells Us About Bristol-Myers Squibb
Jul 1 BMY Bristol-Myers Squibb to Pay $2.7 Million to Settle Potential Anti-Competition Case, Israeli Agency Says
Jul 1 GILD Gilead Benefit Helps Employees Navigate Cancer Care
Jul 1 INO Inovio Pharmaceuticals added to Russell 2000 index effective July 1
Jul 1 BMY Bristol Myers to pay $2.7 million to settle Israel anti-competition charges
Jul 1 INO INOVIO Added to Russell 2000® Index Effective July 1, 2024
Jul 1 BMY Eisai and Bristol Myers cancel cancer ADC deal
Jul 1 GILD Should You Hold Gilead Sciences (GILD)?
Jul 1 GILD 3 Magnificent Stocks Retirees Can Buy and Hold Forever
Jun 28 BMY Bristol-Myers Squibb: Time To Double Down
Immunodeficiency

Immunodeficiency, also known as immunocompromisation, is a state in which the immune system's ability to fight infectious diseases and cancer is compromised or entirely absent. Most cases are acquired ("secondary") due to extrinsic factors that affect the patient's immune system. Examples of these extrinsic factors include HIV infection and environmental factors, such as nutrition.
Immunocompromisation may also be due to genetic diseases/flaws. An example here is SCID.
In clinical settings, immunosuppression by some drugs, such as steroids, can either be an adverse effect or the intended purpose of the treatment. Examples of such use is in organ transplant surgery as an anti-rejection measure and in patients suffering from an overactive immune system, as in autoimmune diseases. Some people are born with intrinsic defects in their immune system, or primary immunodeficiency.A person who has an immunodeficiency of any kind is said to be immunocompromised. An immunocompromised individual may particularly be vulnerable to opportunistic infections, in addition to normal infections that could affect anyone. It also decreases cancer immunosurveillance, in which the immune system scans the body's cells and kills neoplastic ones.

Browse All Tags